CPT 0290T — CORNEAL INCISIONS IN THE RECIPIENT CORNEA CREATED USING A LASER, IN PREPARATION FOR PENETRATING OR LAMELLAR KERATOPLASTY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE) (165 hospitals, — samples)
CPT 0294T — HInsertion of left atrial hemodynamic monitor; pressure sensor lead at time of insertion of pacing cardioverter-defibrillator pulse generator including radiological supervision and interpretation and (124 hospitals, — samples)
CPT 0299U — Oncology (pan tumor), whole genome optical genome mapping of paired malignant and normal DNA specimens, fresh frozen tissue, blood, or bone marrow, comparative structural variant identification (377 hospitals, — samples)
CPT 0300T — HExtracorporeal shock wave for integumentary wound healing, high energy, including topical application and dressing care; each additional wound (List separately in addition to code for primary proced (137 hospitals, — samples)
CPT 0300U — ONC PAN TUM WHL GEN SEQ&OPT (377 hospitals, — samples)
CPT 0301T — HDestruction/reduction of malignant breast tumor with externally applied focused microwave, including interstitial placement of disposable catheter with combined temperature monitoring probe and micr (150 hospitals, — samples)
CPT 0301U — Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR); (386 hospitals, — samples)
CPT 0302T — INSERTION OR REMOVAL AND REPLACEMENT OF INTRACARDIAC ISCHEMIA MONITORING SYSTEM INCLUDING IMAGING S (129 hospitals, — samples)
CPT 0303U — Hematology, red blood cell (RBC) adhesion to endothelial/subendothelial adhesion molecules, functional assessment, whole blood with algorithmic analysis and result reported as an RBC adhesion index; h (386 hospitals, — samples)
CPT 0305U — Hematology, red blood cell (RBC) functionality and deformity as a function of shear stress, whole blood, reported as a maximum elongation index (386 hospitals, — samples)
CPT 0306U — Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient specific panel for future comparisons to ev (378 hospitals, — samples)